You are here: Industry Insights > FDA

News List

Pharmaceutical News of the Week (July. 13th-July. 17th) | PharmaSources.com - Updates on Approvals PharmaSources/Caicai
July 22, 2020
With the third week of July coming to a close, let’s review the hot events of the pharmaceutical industry this week. The news involved 5 sections: approval, R&D, policies, transactions, and miscellany that happened during July 13-17, including 30 pieces.
Pharmaceutical News of the Week (July. 6th-July. 10th) | PharmaSources.com - Updates on Approvals PharmaSources/Caicai
July 21, 2020
With the second week of July coming to a close, let’s review the hot events of the pharmaceutical industry this week.The news involved 6 sections: approval, R&D, policies, transactions, listing and miscellany that happened during July 6-10.
Pharmaceutical News of the Week (June. 29th-July. 3rd) | PharmaSources.com - Updates on Approvals PharmaSources/Caicai
July 08, 2020
Let’s review the hot events of the pharmaceutical industry this week. The news involved 5 sections: approval, R&D, policies, transactions and listing that happened during June 29-July 3, including 29 pieces.
Overseas Marketing of Fruquintinib Accelerated as It Receives the FDA’s Fast Track Designation PharmaSources/Xiaoyaowan
July 06, 2020
Hutchison MediPharma’s targeted anticancer drug: fruquintinib has recently received the Fast Track designation granted by the FDA for the treatment of patients with metastatic colorectal cancer (mCRC).
Pharmaceutical News of the Week (June.22-27) | PharmaSources.com PharmaSources/Caicai
July 01, 2020
With the last week of June coming to a close, let’s review the hot events of the pharmaceutical industry this week. The news involved 5 sections: approval, R&D, policies, transactions and listing that happened during June 22-28, including 22 pieces.
Pharma and Health from Ingredients to Pills: FDA Drug Recalls 101 Lin Zhang
June 15, 2020
Pharmaceutical drug use in the USA dates back more than a century, and the use of these drugs led to creation of new acts or changes to the existing ones.
Conducting Clinical Trials amid the COVID-19 Outbreak: FDA Encourages Sponsors to Go Virtual Neeta Ratanghayra
April 08, 2020
For pharmaceutical companies, one of the most significant operational impacts of the COVID-19 is on clinical trials. On March 19, 2020, the U.S. Food and Drug Administration (FDA) issued guidance on the conduct of clinical trials during the COVID-19 pande
Navi Medical Technologies' Neonav® ECG Tip Location System Receives FDA 510(k) Clearance PR Newswire
February 17, 2025
FDA 510(k) Clearance Revolutionising Vascular Access Care for Critically Ill Newborns and Children
Innovent Receives Second Fast Track Designation from the U.S. FDA for IBI363 in Squamous Non-Small Cell Lung Cancer PR Newswire
February 17, 2025
Innovent Receives FDA for IBI363 in Squamous Non-Small Cell Lung Cancer
FDA Clears World's First Mobile App for Contactless Pulse Rate Measurement PharmaSources
January 26, 2025
On Jan. 26, Hong Kong - based PanopticAI announced getting FDA 510(k) clearance for its contactless vital signs monitoring software, turning mobile devices into medical - grade monitors.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 366 367 Next page